Wen Qi Hu
Directeur/Bestuurslid bij Beijing Mabworks Biotech Co., Ltd.
Actieve functies van Wen Qi Hu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Directeur/Bestuurslid | 26-03-2020 | - |
| Corporate Officer/Principal | 01-06-2017 | - |
Loopbaan van Wen Qi Hu
Eerdere bekende functies van Wen Qi Hu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd.
 Suzhou Chuangsheng Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology MabSpace Biosciences (Suzhou) Co., Ltd. engages in the development of therapeutic antibodies for cancer and fibrotic diseases. Its products include humanized programmed death-ligand 1, humanized vascular endothelial growth factor receptors 2, humanized OX40, and humanized colony stimulating factor 1 receptor antibodies. It also offers programmed death-ligand 1 antibodies for Immunohistochemistry detection and soluble programmed death ligand 1 measurement. The company was founded by Xue Ming Qian on October 18, 2012 and is headquartered in Suzhou, China. | Corporate Officer/Principal | 01-09-2016 | 01-05-2017 |
| Crownbio Bioscience Taicang Co. Ltd. | Directeur/Bestuurslid | 01-02-2013 | 01-08-2016 |
| Hunan Normal University | Corporate Officer/Principal | 01-07-1986 | 01-02-1996 |
Opleiding van Wen Qi Hu
| Hunan Agricultural University | Undergraduate Degree |
| Nanjing Agricultural University | Graduate Degree |
Statistieken
Internationaal
| China | 6 |
| 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd.
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology MabSpace Biosciences (Suzhou) Co., Ltd. engages in the development of therapeutic antibodies for cancer and fibrotic diseases. Its products include humanized programmed death-ligand 1, humanized vascular endothelial growth factor receptors 2, humanized OX40, and humanized colony stimulating factor 1 receptor antibodies. It also offers programmed death-ligand 1 antibodies for Immunohistochemistry detection and soluble programmed death ligand 1 measurement. The company was founded by Xue Ming Qian on October 18, 2012 and is headquartered in Suzhou, China. | Health Technology |
| Crownbio Bioscience Taicang Co. Ltd. |
